OPEN END TURBO BULL - BB BIOTECH N Share Price

Certificat

DE000CW8PRQ0

Delayed Börse Stuttgart 12:47:50 02/05/2024 pm IST
1.44 EUR +2.13% Intraday chart for OPEN END TURBO BULL - BB BIOTECH N
1 month-12.96%
3 months-9.62%
Date Price Change Volume
02/24/02 1.44 +2.13% 0
30/24/30 1.41 +2.92% 0
29/24/29 1.37 +0.74% 0
26/24/26 1.36 -2.16% 0
25/24/25 1.39 -0.71% 0

Delayed Quote Börse Stuttgart

Last update May 02, 2024 at 12:47 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying BB BIOTECH AG
IssuerLogo Issuer Citi Citi
WKN CW8PRQ
ISINDE000CW8PRQ0
Date issued 22/01/2016
Strike 13.85 CHF
Maturity Unlimited
Parity 20 : 1
Emission price 0.76
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.43
Lowest since issue 0.47

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
41.35 CHF
Average target price
47.7 CHF
Spread / Average Target
+15.36%
Consensus